Metrizamide
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
2-({3-(acetylamino)-5-[acetyl(methyl)amino]-2,4,6-triiodobenzoyl}amino)-2-deoxy-D-glucopyranose | |
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Identifiers | |
| CAS Number |
31112-62-6 |
| ATC code | V08AB01 |
| PubChem | CID 443944 |
| ChemSpider |
391998 |
| UNII |
RHH3W8F1CO |
| ChEMBL |
CHEMBL1200889 |
| Synonyms | 3-acetamido-2,4,6-triiodo-5-(N-methylacetamido)-N-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]benzamide |
| Chemical data | |
| Formula | C18H22I3N3O8 |
| Molar mass | 789.10 g/mol |
| | |
Metrizamide is a nonionic radiopaque contrast agent.
| ||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Thursday, October 29, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
